NCT00057408View on ClinicalTrials.gov

A Controlled Study of Olanzapine in Children With Autism

PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

September 30, 2005

Conditions
Autistic Disorder
Interventions
DRUG

olanzapine (Zyprexa)

Olanzapine tablets given po at a dosage of 2.5 - 20 mg per day for up to 12 weeks.

DRUG

Placebo

Matching Placebo

Trial Locations (1)

19124

Drexel University College of Medicine c/o Friends Hospital, Philadelphia

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

FDA Office of Orphan Products Development

FED

NCT00057408 - A Controlled Study of Olanzapine in Children With Autism | Biotech Hunter | Biotech Hunter